In vitro activities of tigecycline against clinical isolates from Shanghai, China
- 31 December 2004
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 50 (4) , 267-281
- https://doi.org/10.1016/j.diagmicrobio.2004.08.007
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Activities of the Glycylcycline Tigecycline (GAR-936) against 1,924 Recent European Clinical Bacterial IsolatesAntimicrobial Agents and Chemotherapy, 2003
- In Vitro Activities of Tigecycline (GAR-936) against Recently Isolated Clinical Bacteria in SpainAntimicrobial Agents and Chemotherapy, 2002
- In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum β-lactamasesDiagnostic Microbiology and Infectious Disease, 2001
- Comparative In Vitro Activities of GAR-936 against Aerobic and Anaerobic Animal and Human Bite Wound PathogensAntimicrobial Agents and Chemotherapy, 2000
- In Vitro Activities of the Glycylcycline GAR-936 against Gram-Positive BacteriaAntimicrobial Agents and Chemotherapy, 2000
- Antipneumococcal Activities of GAR-936 (a New Glycylcycline) Compared to Those of Nine Other Agents against Penicillin-Susceptible and -Resistant PneumococciAntimicrobial Agents and Chemotherapy, 2000
- Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997–1998Journal of Antimicrobial Chemotherapy, 2000
- Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolatesDiagnostic Microbiology and Infectious Disease, 2000
- Introduction: Problems with Antimicrobial Resistance in Gram‐Positive CocciClinical Infectious Diseases, 1998
- Evolution and spread of tetracycline resistance determinantsJournal of Antimicrobial Chemotherapy, 1989